Skip to main content
  • Prasugrel Leads P2Y12 Inhibitors for STEMI Still needed: consensus on bridging to oral agents

    Adverse outcomes after primary percutaneous coronary intervention (PCI) for patients

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details